The longitudinal association between anticholinergic burden and cognitive‐functional decline among older adults
Our findings, based on combined measures in assessing cognitive-functional decline in older adults, support incorporating anticholinergic burden assessment into routine care, particularly for patients aged ≥85 or those with CNS diseases and depression.
Authors
- Hani Dimassi (ORCID: https://orcid.org/0000-0003-1827-2453)
- Etwal Bou Raad (ORCID: https://orcid.org/0000-0001-5269-9229)
- Laurent Becquemont
- Khalil El Asmar
- Philippe Bertin
- Lilian Ghandour
- Emmanuelle Corruble
- Monique Chayaa
Institutions
- Université Paris-Sud (FR)
- Inserm (FR)
- Université Paris-Saclay (FR)
- Yale University (US)
- Assistance Publique – Hôpitaux de Paris (FR)
- Centre de recherche en Epidémiologie et Santé des Populations (FR)
- American University of Technology (LB)
- Bicêtre Hospital (FR)
- Université de Limoges (FR)
- American University of Beirut (LB)
Publication Details
- Journal
- British Journal of Clinical Pharmacology
- Published
- 2026-01-21
- DOI
- https://doi.org/10.1002/bcp.70457
- Primary Topic
- Pharmaceutical Practices and Patient Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00